Clinical trialNCT06499285RecruitingPhase 3Interventional

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

SponsorTakedaEnrollment225Myelodysplastic Syndromes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Study Director
Takeda
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

179 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

the Canberra Hospital
Garran, Australian Capital Territory, Australia
Philip Choi
Not, yet, recruiting
Westmead Hospital
Sydney, New South Wales, Australia
Lachlin Vaughan
Recruiting
Townsville University Hospital
Douglas, Queensland, Australia
Joel Wight
Recruiting
Flinders Medical Centre
Adelaide, South Australia, Australia
David Beligaswatte
Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Devendra Hiwase
Recruiting
Box Hill Hospital
Box Hill, Victoria, Australia
Stephen Ting
Recruiting
St Vincent'S Hospital (melbourne) Ltd
Fitzroy, Victoria, Australia
ShuhYing Tan
Recruiting
Alfred Health
Melbourne, Victoria, Australia
Shaun Fleming
Not, yet, recruiting
Peter Maccallum Cancer Center
Parkville, Victoria, Australia
Lynette Chee
Recruiting

Brazil

Hosptial Erasto Gaertner
Curitiba, Paraná, Brazil
Eduardo Munhoz
Not, yet, recruiting
Hospital Mae de Deus, Clinical Research Unit - Cancer Institute
Porto Alegre, Rio Grande do Sul, Brazil
Marcelo Capra
Recruiting
Pontifical University of Rio Grande Do Sul (pucrs) - St. Luke Hospital
Porto Alegre, Rio Grande do Sul, Brazil
Mariza Schaan
Recruiting
Porto Alegre Clinical Hospital (hcpa)
Porto Alegre, Rio Grande do Sul, Brazil
Laura Maria Fogliatto
Recruiting
Instituto Joinvilense de Hematologia E Oncologia
Joinville, Santa Catarina, Brazil
Lacerda Marcelo
Not, yet, recruiting
Fundaaao Doutor Amaral Carvalho
Jaú, São Paulo, Brazil
Guilherme Mattos
Not, yet, recruiting
Cepho- Fmabc
Santo André, São Paulo, Brazil
Vitor Mauad
Not, yet, recruiting
Sao Jose Do Rio Preto Regional Faculty of Medicine Foundation
São José do Rio Preto, São Paulo, Brazil
Mariana Buka
Recruiting
Americas Institute
Rio de Janeiro, Brazil
Fernando Correia Pinto
Recruiting
Hospital A.C.Camargo ("antonio Prudente" Foundation)
São Paulo, Brazil
Marina Nascimento
Recruiting
Portuguese Charity of Sao Paulo, Clinical Hematology / Oncology Center
São Paulo, Brazil
Phillip Scheinberg
Recruiting
Santa Casa of Mercy of Santos
São Paulo, Brazil
Elaine Mancilha
Not, yet, recruiting

Bulgaria

Dr. Pencho Georgiev - Outpatient Center for Individual Practice for Specialized Medical Care in Internal Medicine and Clinical Hematology (eood)
Plovdiv, Bulgaria
Pencho Georgiev
Recruiting
Multiprofile Hospital for Active Treatment - Sofia, Part of Military Medical Academy, Clinic of Hematology
Sofia, Bulgaria
Viktoria Barbukova
Recruiting
Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Clinic of Hematology
Sofia, Bulgaria
Tanya Yankova
Recruiting
University Multiprofile Hospital for Active Treatment "sveti Ivan Rilski", Sofia, Clinic of Clinical Hematology
Sofia, Bulgaria
Atanas Radinoff
Recruiting
University Multiprofile Hospital for Active Treatment "sveta Marina", Clinic of Clinical Hematology
Varna, Bulgaria
Ilina Micheva
Not, yet, recruiting

Canada

University of Alberta Hospital
Edmonton, Alberta, Canada
Nancy Zhu
Recruiting
Providence Hematology - Vancouver
Vancouver, British Columbia, Canada
Heather Leitch
Recruiting
Nova Scotia Health Authority, Centre for Clinical Research
Halifax, Nova Scotia, Canada
Amy Trottier
Recruiting
London Health Sciences Centre
London, Ontario, Canada
Lalit Saini
Recruiting
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Karen Yee
Recruiting
Sunnybrook Research Institute, Odette Cancer Center
Toronto, Ontario, Canada
Rena Buckstein
Recruiting

Chile

Dr. Guillermo Grant Benavente - Concepcion Regional Hospital
Concepción, Biobio, Chile
Monica Romero
Recruiting
Ic la Serena Research
La Serena, Coquimbo Region, Chile
Cleiden Villegas
Recruiting
Center for Clinical Studies and Medical Research (cecim)
Santiago, Chile
Alexander Arellano
Recruiting
Clinic Inmunocel
Santiago, Chile
Alejandro Berkovits
Recruiting
Saga Clinical Research Center Spa
Santiago, Chile
Ada Hernandez
Recruiting

Czechia

University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology
Brno, Czechia
Jiri Mayer
Not, yet, recruiting
University Hospital Hradec Kralove, 4th Internal Clinic of Hematology
Hradec Králové, Czechia
Petra Belohlavkova
Recruiting
University Hospital Ostrava and Faculty of Medicine, University of Ostrava
Ostrava, Czechia
Zdenek Koristek
Not, yet, recruiting

139 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Elritercept →Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 May 2025
Primary completion: 1 May 2028
Completion: 1 May 2032
Last update posted: 13 May 2026
Registered enrollment: 225
Registry id: NCT06499285

Cross-registrations

EU-CTR / CTIS (EudraCT)2024-516009-22-00

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.